A boxed warning is the most serious warnings from the Food and Drug Administration (FDA), highlighting potential life-threatening side effects that need careful consideration before using the medication
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
Options include staying at your current dose longer before increasing, temporarily reducing to your previous dose level, implementing more aggressive side effect management strategies, or in some cases discontinuing treatment
APPEAL PROCESS What to Do If Medicare Denies Wegovy Medicare Appeals Have High Success Rates Over 80% of Medicare Advantage prior authorization appeals succeed yet only about 11% of patients ever appeal, according to KFF analysis of CMS data